Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: Nature Publishing Group
Languages: English
Types: Article
Subjects: SF600, QR180, RC0254, QH
BPV-4 E5 inhibits transcription of the bovine MHC class I heavy chain (HC) gene, increases degradation of HC and downregulates surface expression of MHC class I by retaining the complex in the Golgi apparatus (GA). Here we report that transcription inhibition can be alleviated by interferon treatment and the degradation of HC can be reversed by treatment with inhibitors of proteasomes and lysosomes. However, the inhibition of transport of MHC class I to the cell surface is irreversible. We show that E5 is capable of physically interacting with HC. Together with the inhibition of the vacuolar ATPase (due to the interaction between E5 and 16k subunit c), the interaction between E5 and HC is likely to be responsible for retention of MHC class I in the GA. C-terminus deletion mutants of E5 are incapable of either downregulating surface MHC class I or interacting with HC, establishing that the C-terminus domain of E5 is important in the inhibition of MHC class I.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Agrawal, S. & Kishore, M. (2000). J Hematother Stem Cell Res., 9, 795-812.
    • Anderson, R.A., Scobie, L., O'Neil, B.W., Grindlay, G.J. & and Campo, M.S. (1997). Veterin. J., 154, 69-78.
    • Araibi, E.H., Marchetti, B., Ashrafi, G.H. & Campo, M.S. (2004). Journal of General Virology, 85, 2809-2814.
    • Ashby, A.D.M., Meagher, L., Campo, M.S. & Finbow, M.E. (2001). J. Gen. Virol., 82, 2353-2362.
    • Ashrafi, G.H., Haghshenas, M.R., Marchetti, B., O'Brien, P.M. & Campo, M.S. (2005). International Journal of Cancer, 113, 276-283. Published online: 25 Aug 2004.
    • Ashrafi, G.H., Pitts, J.D., Faccini, A., McLean, P., O'Brien, V., Finbow, M.E. & Campo, S. (2000). J Gen Virol, 81 Pt 3, 689-94.
    • Ashrafi, G.H., Tsirimonaki, E., Marchetti, B., O'Brien, P.M., Sibbet, G.J., Andrew, L. & Campo, M.S. (2002). Oncogene, 21, 248-59.
    • Bartee, E., Mansouri, M., Hovey Nerenberg, B.T., Gouveia, K. & Fruh, K. (2004). J. Virol., 78, 1109-1120.
    • Bensaid, A., Kaushal, A., Machugh, N.D., Shapiro, S.Z. & Teale, A.J. (1989). Anim Genet, 20, 241-55.
    • Burkhardt, A., Willingham, M., Gay, C., Jeang, K.T. & Schlegel, R. (1989). Virology, 170, 334-9.
    • Chevalier, M.S., Daniels, G.M. & Johnson, D.C. (2002). J. Virol., 76, 8265-8275.
    • DiMaio, D. & Mattoon, D. (2001). Oncogene, 20, 7866-73.
    • Disbrow, G.L., Hanover, J.A. & Schlegel, R. (2005). J. Virol., 79, 5839-5846.
    • Ellis, S.A., Staines, K.A. & and Morrison, W.I. (1996). Immunogenetics, 43, 156-159.
    • Faccini, A.M., Cairney, M., Ashrafi, G.H., Finbow, M.E., Campo, M.S. & Pitts, J.D. (1996). J Virol, 70, 9041-5.
    • Furman, M.H., Dey, N., Tortorella, D. & Ploegh, H.L. (2002). J. Virol., 76, 11753- 11756.
    • Gaddum, R.M., Willis, A.C. & and Ellis, S.A. (1996). Immunogenetics., 43, 238-239.
    • Goldstein, D., Andresson, T, Sparkowski, JJ, Schlegel, R. (1992). EMBO J., 11, 4851- 4859.
    • Goldstein, D.J., Finbow, M.E., Andresson, T., McLean, P., Smith, K., Bubb, V. & Schlegel, R. (1991). Nature, 352, 347-9.
    • Goldstein, D.J., Kulke, R., Dimaio, D. & Schlegel, R. (1992). J Virol, 66, 405-13.
    • Graham, S.P., Jones, G.E., MacLean, M., Livingstone, M. & Entrican, G. (1995). J Comp Pathol., 112, 185-195.
    • Grindlay, G., Campo, M. & and O'Brien, V. (2005). Virus Research, 108, 29-38.
    • Hewitt, E.W., Duncan, L., Mufti, D., Baker, J., Stevenson, P.G. & Lehner, P.J. (2002). EMBO J., 21, 2418-2429.
    • Hughes, E.A., Hammond, C. & Cresswell, P. (1997). Proc Natl Acad Sci U S A, 94.
    • Kasper, M.R. & Collins, K.L. (2003). J. Virol., 77, 3041-3049.
    • Klein, O., Kegler-Ebo, D., Su, J., Smith, S. & DiMaio, D. (1999). J Virol, 73, 3264-72.
    • Klein, O., Polack, G.W., Surti, T., Kegler-Ebo, D., Smith, S.O. & DiMaio, D. (1998). J Virol, 72, 8921-32.
    • Lai, C.C., Henningson, C. & DiMaio, D. (2000). J Biol Chem, 275, 9832-40.
    • Lu, X., Yu, H., Liu, S.H., Brodsky, F.M. & Peterlin, B.M. (1998). Immunity, 8, 647- 656.
    • n 5 u 5+
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article